The Effect of Continuous-Flow Left Ventricular Assist Device Duration on Postoperative Outcomes Dhaval Chauhan, MD, Alexis K. Okoh, MD, Nicky Haik, BA, Nathan Kang, MS, Michael Choi, BA, David Baran, MD, Mark Zucker, MD, Magarita Camacho, MD, Mark J. Russo, MD The Annals of Thoracic Surgery Volume 104, Issue 6, Pages 1933-1938 (December 2017) DOI: 10.1016/j.athoracsur.2017.05.070 Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Kaplan-Meier survival curves for patient groups stratified by duration on continuous-flow left ventricular assist device support. The Annals of Thoracic Surgery 2017 104, 1933-1938DOI: (10.1016/j.athoracsur.2017.05.070) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Actuarial survival rates for patient groups at 1-year, 2-year, and 5-year follow-up assessments. The Annals of Thoracic Surgery 2017 104, 1933-1938DOI: (10.1016/j.athoracsur.2017.05.070) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions